Quarterly report pursuant to Section 13 or 15(d)

Liquidity - Additional Information (Details)

v3.22.2.2
Liquidity - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 01, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Subsequent Event [Line Items]            
Accumulated deficit   $ 39,460,016   $ 39,460,016   $ 21,525,710
Working capital   1,694,861   1,694,861    
Total debt   0   0    
Cash and cash equivalents   4,747,951 $ 1,190,974 4,747,951 $ 1,190,974 $ 19,183,044
Net loss   $ 5,779,860 $ 4,792,579 17,934,306 10,256,167  
Cash flows from operations       $ 15,339,217 $ 5,526,568  
Subsequent Event | Maestro Health LLC            
Subsequent Event [Line Items]            
Purchase price $ 0          
Free cash reserves agreed $ 15,790,000